Checkpoint Trends Ltd (531099) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531099 | NSE: | Trading | Small Cap

Rubra Medicaments Share Price

109.56 2.14 1.99%
as on 05-Dec'25 12:16

Checkpoint Trends Ltd (531099) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531099 | NSE: | Trading | Small Cap

DeciZen - make an informed investing decision on Rubra Medicaments

Based on:

M-Cap below 100cr DeciZen not available

Checkpoint Trends stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
40.34
Market Cap:
58.7 Cr.
52-wk low:
9.4
52-wk high:
107.4

Is Checkpoint Trends Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Rubra Medicaments: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Checkpoint Trends Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -1.8%9.1%-32.2%-1.9%8%1.4%-3.7%-13.1%4.5%9.6%-
Value Creation
Index
-1.1-0.4-3.3-1.1-0.4-0.9-1.3-1.9-0.7-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.20.32.30.610.521.21.10.5121
Sales YoY Gr.-55%641.9%-74.4%67.8%-50.5%310.2%-42.3%-2.6%-55.8%-
Adj EPS -00.10.1-0.200-0.1-0.10.10.12.7
YoY Gr.-NA16.7%-442.9%NA-50%-800%NANA66.7%-
BVPS (₹) 0.70.80.50.40.50.50.50.3113.6
Adj Net
Profit
-000-0.100-0-0.100.11
Cash Flow from Ops. -000.2-00.10.5-0.50-00.2-
Debt/CF from Ops. 000000010.700-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.7%-12.8%-37.1%-55.8%
Adj EPS NA38%NA66.7%
BVPS4.3%15.3%31.4%5.2%
Share Price 54.1% 117.7% 198% 570.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-1.88.57.5-22.41.70.9-6.1-14.55.810.4115.2
Op. Profit
Mgn %
-3.511.2-1.5-30.71.82.1-1.1-6.82.920.81.6
Net Profit
Mgn %
-3.511.11.7-22.211.2-1.8-6.82.711.31.2
Debt to
Equity
00000000.9000
Working Cap
Days
6554376731423641810821822853788
Cash Conv.
Cycle
33-2112122941928017218336251

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Checkpoint Trends Ltd.

Standalone Consolidated
TTM EPS (₹) 2.7 -
TTM Sales (₹ Cr.) 121 -
BVPS (₹.) 3.6 -
Reserves (₹ Cr.) -3 -
P/BV 29.81 -
PE 40.34 -
From the Market
52 Week Low / High (₹) 9.41 / 107.42
All Time Low / High (₹) 0.96 / 103.26
Market Cap (₹ Cr.) 58.7
Equity (₹ Cr.) 5.5
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of Rubra Medicaments:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Rubra Medicaments - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Rubra Medicaments

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.200.312.300.590.990.492.011.161.130.50
Operating Expenses 0.200.272.330.770.970.482.031.241.100.44
Manufacturing Costs000.160.01000.170.190.010.01
Material Costs0.130.121.890.330.150.080.52000
Employee Cost 0.020.020.130.210.130.200.230.350.500.26
Other Costs 0.060.130.160.230.690.201.120.700.580.17
Operating Profit -0.010.03-0.03-0.180.020.01-0.02-0.080.030.06
Operating Profit Margin (%) -3.5%11.2%-1.5%-30.7%1.8%2.1%-1.1%-6.8%2.9%11.8%
Other Income 000.160000000
Interest 0000000000.01
Depreciation 000000000.010.01
Exceptional Items 00-0.290.170.0300000
Profit Before Tax -0.010.03-0.16-0.010.050.01-0.02-0.080.020.05
Tax 00000.0100.01-0-0.010.02
Profit After Tax -0.010.03-0.16-0.010.030.01-0.04-0.080.030.03
PAT Margin (%) -3.5%11.1%-7.1%-1.9%3.2%1.2%-1.8%-6.8%2.7%5.1%
Adjusted EPS (₹)-0.00.1-0.3-0.00.10.0-0.1-0.10.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.380.420.250.240.270.280.240.170.530.56
Share Capital 5.475.475.475.475.475.475.475.475.475.47
Reserves -5.08-5.05-5.21-5.23-5.19-5.19-5.22-5.30-4.94-4.91
Minority Interest0000000000
Debt00000000.1500
Long Term Debt0000000000
Short Term Debt00000000.1500
Trade Payables00.030.170.06000000
Others Liabilities 0.070.080.390.400.480.620.600.350.390.09
Total Liabilities 0.460.530.810.700.750.900.850.660.930.65

Fixed Assets

Gross Block0000.020.020.020.020.070.080
Accumulated Depreciation00000000.010.010
Net Fixed Assets 0000.020.020.010.010.060.070
CWIP 0000000000
Investments 0000000000
Inventories0000000000
Trade Receivables0.020.020.340.290.290.220.670.430.710.29
Cash Equivalents 0.100.160.340.1400.520.020.030.010.03
Others Assets 0.350.350.130.250.450.150.150.140.140.34
Total Assets 0.460.530.810.700.750.900.850.660.930.65

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.010.040.18-0.030.120.52-0.500.01-00.19
PBT -0.010.030.12-0.180.020.01-0.02-0.080.020.05
Adjustment 000000000.010.05
Changes in Working Capital 000.05-0.010.080.51-0.470.09-0.030.09
Tax Paid 0000-0.01-0-0.01000
Cash Flow From Investing Activity 00000000-0.01-0.18
Capex 00000000-0.010.02
Net Investments 0000000000
Others 000000000-0.20
Cash Flow From Financing Activity -0.020.020-0.17-0.2600000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0.020.020-0.17-0.2600000
Net Cash Flow -0.030.060.18-0.20-0.140.52-0.500.01-0.020.01

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-1.768.48-48.73-4.5912.22.02-13.95-38.448.664.66
ROCE (%)-1.759.13-32.23-1.877.981.37-3.7-13.14.539.64
Asset Turnover Ratio0.420.623.420.781.360.592.31.541.430.63
PAT to CFO Conversion(x)N/A1.33N/AN/A452N/AN/A-06.33
Working Capital Days
Receivable Days33212919710819280172184362
Inventory Days0000000000
Payable Days01001912574319100

Checkpoint Trends Ltd Stock News

Checkpoint Trends Ltd FAQs

The current trading price of Rubra Medicaments on 05-Dec-2025 12:16 is ₹109.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Rubra Medicaments stood at ₹58.74.
The latest P/E ratio of Rubra Medicaments as of 04-Dec-2025 is 40.34.
The latest P/B ratio of Rubra Medicaments as of 04-Dec-2025 is 29.81.
The 52-week high of Rubra Medicaments is ₹107.4 and the 52-week low is ₹9.41.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rubra Medicaments is ₹120.7 ( Cr.) .

About Checkpoint Trends Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×